CA
ZYME icon

Clearstead Advisors’s Zymeworks ZYME Stock Holding History

Clearstead Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157 Buy
+6
New +$152 ﹤0.01% 3261
2025
Q4 		– Sell
-5,001
Closed -$85.4K – 3301
2025
Q3 		$85.4K Buy
5,001
+1
+0% +$14 ﹤0.01% 1096
2025
Q2 		$62.8K Hold
5,000
– – ﹤0.01% 1212
2025
Q1 		$59.5K Hold
5,000
– – ﹤0.01% 1130
2024
Q4 		$73.2K Hold
5,000
– – ﹤0.01% 1084
2024
Q3 		$62.8K Hold
5,000
– – ﹤0.01% 1153
2024
Q2 		$42.5K Buy
+5,000
New +$44.5K ﹤0.01% 1203

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Clearstead Advisors's ZYME Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Zymeworks (ZYME) in Q2 2026: 6 shares worth $157. The stake represents ﹤0.01% of the portfolio and ranks #3261 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in ZYME as recently as Q3 2025.

Clearstead Advisors first reported a position in ZYME in Q2 2024 and has held it in 7 quarters since. The position peaked at $85.4K in Q3 2025. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Clearstead Advisors held 6 shares of Zymeworks worth $157 as of Q2 2026.
  • Zymeworks was a new Clearstead Advisors position in Q2 2026.
  • Zymeworks made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3261 holding.
  • Clearstead Advisors first reported a position in Zymeworks in Q2 2024 and has held it in 7 quarters since.
  • Clearstead Advisors's Zymeworks position peaked at $85.4K in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.